Jasveen Sangha is expected to be sentenced on Wednesday after pleading guilty to selling a fatal dose of ketamine to actor Matthew Perry. The case has already exposed a wider chain of conduct, but the central question remains: how did a single drug sale become part of a broader pattern of continued distribution, multiple defendants, and a death that prosecutors say should now carry a 15-year prison term?
Why is Jasveen Sangha facing a sentence that could reach 65 years?
Verified fact: federal prosecutors have asked for a 15-year sentence for Jasveen Sangha, saying her role extended beyond Perry and included another death tied to her conduct. Sangha, 42, has already pleaded guilty and is the fifth defendant to take a plea deal and admit guilt in the case.
Perry died at age 54 in October 2023, and officials ruled ketamine the primary cause of death. He had previously received ketamine legally for depression treatment, but his doctor refused to provide the amounts he wanted. He then sought the drug from other sources.
Informed analysis: The sentencing hearing is not only about punishment for one transaction. It is about whether the court treats Sangha’s conduct as an isolated sale or as part of a sustained distribution pattern that prosecutors say continued even after she learned of deaths linked to her drugs.
What does the plea agreement say about Jasveen Sangha’s conduct?
The plea agreement states that Sangha distributed drugs, including ketamine and meth, from her home in North Hollywood since 2019. It also says she sold ketamine to Cody McLaury, 33, who died in 2019 shortly after purchasing the drugs, and later to Perry. Prosecutors say she continued dealing after learning of those deaths.
In court documents, the prosecution described her actions as showing “cold callousness and disregard for life, ” adding that she “chose profits over people. ” They also said her background included attendance at a “well-respected university” and a master’s degree, and argued that she sought to sell drugs for “greed, [glamour], and access. ”
Verified fact: authorities charged five people in connection with the case: two doctors, Salvador Plasencia and Mark Chavez; Perry’s assistant Kenneth Iwamasa; Erik Fleming, an acquaintance of Perry’s; and Sangha. The doctors did not supply the ketamine that killed Perry, but a judge told Plasencia that he and others helped the actor on the road to his death by “continuing to feed his ketamine addiction. ”
Who benefits from the defense narrative around rehabilitation?
The defense, led by Mark Geragos and Alexandra Kazarian, says Sangha has admitted responsibility and does not minimize her conduct. It argues that she has no criminal history and has taken part in recovery and rehabilitation programs while incarcerated.
The defense has also said Sangha has shown “two years of sustained sobriety, consistent engagement in recovery programming, and strong community support, ” framing her as a person with a meaningful commitment to change and a low risk of recidivism. It is asking for release with time served.
Verified fact: the judge is not required to follow either sentencing request. Sangha could spend as long as 65 years in prison.
What does the case reveal when the facts are read together?
The case now hinges on two competing interpretations. The prosecution says Jasveen Sangha operated with sustained disregard for life, kept distributing drugs after prior deaths, and helped fuel a chain that ended with Perry’s death. The defense says she has accepted responsibility, participated in recovery, and should not face a lengthy prison term.
Informed analysis: What makes the case unusually severe is not only the fatal dose tied to Perry, but the picture prosecutors have built around continuing conduct, multiple victims, and a defendant they say did not stop after seeing the consequences. That combination is why the sentencing carries symbolic weight beyond one courtroom.
The public record in this case already shows a prosecutorial demand for a major sentence, a defense plea for leniency, and a judge with broad discretion. The next decision will determine whether the court treats Jasveen Sangha as a remorseful defendant seeking rehabilitation or as a central figure in a wider and deadlier drug network.
For now, the sentence will stand as the clearest test of how the justice system weighs responsibility, rehabilitation, and the cost of Jasveen Sangha.
